Our study provides novel insight into how FOXM1 mediates its oncogenic signaling in GBM cells where FOXM1 regulates AXL and eEF2K, both of which orchestrate GBM proliferation, invasiveness, and therapeutic resistance. Here, AXL is linked to glioblastoma.